📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. (2022)

First Author: Parry H

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2022.100739

PubMed Identifier: 36075216

Publication URI: http://europepmc.org/abstract/MED/36075216

Type: Journal Article/Review

Volume: 3

Parent Publication: Cell reports. Medicine

Issue: 9

ISSN: 2666-3791